-
1 Comment
Houston We Have Limited is currently in a long term uptrend where the price is trading 86.8% above its 200 day moving average.
From a valuation standpoint, the stock is 78.4% cheaper than other stocks from the Technology sector with a price to sales ratio of 15.4.
Houston We Have Limited's total revenue rose by 139.5% to $502K since the same quarter in the previous year.
Its net income has increased by 42.5% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 38.4% to $-346K since the same quarter in the previous year.
Based on the above factors, Houston We Have Limited gets an overall score of 5/5.
Exchange | AU |
---|---|
CurrencyCode | AUD |
ISIN | AU0000073439 |
Sector | Software |
Industry | Information Technology |
Dividend Yield | None |
---|---|
PE Ratio | None |
Target Price | None |
Beta | 1.01 |
EchoIQ Limited provides cardiac diagnostics technology solution in Australia. The company's artificial intelligence-assisted diagnostics technology supports the sensitive diagnosis of Aortic Stenosis. It primarily serves device manufacturers, cardio scanning equipment, pharmaceuticals, and healthcare providers and insurers, as well as clinicians and patients. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. EchoIQ Limited is based in St Leonards, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for HWH.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025